Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical ImplicationsMalaney R. O’Connell(Galveston College), Pomila Singh(The University of Texas Medical Branch at Galveston)Scientific ReportsOctober 8, 201510.1038/srep14983Cited by 73SaveCiteExport RISWatch citationsRelated PapersA novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy|Laboratory Investigation|2017|40